Top 10 Warren Buffett Stocks To Watch For 2019

On May 15, I finally did something that I had hoped that I’d never do: I put in a market order in to sell the entirety of my stake in chip giant Intel (NASDAQ:INTC). Within an instant, a position that I’d started building in 2012 and added substantially to in 2013 was gone. 

Intel is a company that I wanted to own for Warren Buffett’s ideal holding period: forever. But, after careful consideration, I decided that this wasn’t a stock that I wanted in my portfolio any longer.

Image source: Intel.

Here’s why.

Some background

Although Intel’s financial execution over the last few years has been solid, deeper down the company’s technology execution has been quite poor.

To understand what I’m talking about when I say that Intel’s technology execution has been poor, I need to explain some basic concepts. 

A computer processor, such as the one that’s powering the device that you’re reading this on, is ultimately judged by the following criteria: 

Top 10 Warren Buffett Stocks To Watch For 2019: Ryerson Holding Corporation(RYI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday afternoon, the materials shares rose 0.49 percent. Meanwhile, top gainers in the sector included Ryerson Holding Corporation (NYSE: RYI), up 11 percent, and Synalloy Corporation (NASDAQ: SYNL) up 10 percent.

  • [By Lee Jackson]

    This top small-cap play could make sense for more aggressive accounts. Ryerson Holdings Inc. (NYSE: RYI) offers a line of stainless steel, aluminum, carbon steel and alloy steels, as well as nickel and red metals in various shapes and forms, including coils, sheets, rounds, hexagons, square and flat bars, plates, structurals and tubings.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ryerson (RYI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ryerson (RYI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lee Jackson]

    Ryerson
    This is a top small-cap play that could make sense for more aggressive accounts. Ryerson Holdings Inc. (NYSE: RYI) offers a line of stainless steel, aluminum, carbon steel and alloy steels, as well as nickel and red metals in various shapes and forms, including coils, sheets, square and flat bars, plates and tubing.

Top 10 Warren Buffett Stocks To Watch For 2019: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Max Byerly]

    AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Ethan Ryder]

    Swiss National Bank lifted its stake in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 5.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 52,200 shares of the medical equipment provider’s stock after purchasing an additional 2,800 shares during the period. Swiss National Bank owned about 0.14% of AxoGen, Inc Common Stock worth $2,623,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System boosted its holdings in AxoGen, Inc Common Stock (NASDAQ:AXGN) by 17.8% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,103 shares of the medical equipment provider’s stock after buying an additional 3,490 shares during the quarter. State Board of Administration of Florida Retirement System owned 0.06% of AxoGen, Inc Common Stock worth $1,161,000 at the end of the most recent quarter.

Top 10 Warren Buffett Stocks To Watch For 2019: Flushing Financial Corporation(FFIC)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub downgraded shares of Flushing Financial (NASDAQ:FFIC) from a sell rating to a strong sell rating in a research note published on Saturday.

  • [By Stephan Byrd]

    Flushing Financial (NASDAQ:FFIC) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Fly Leasing (NYSE:FLY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $17.00 price target on the stock. According to Zacks, “Fly Leasing Limited, formerly known as Babcock & Brown Air Limited, is engaged in acquiring and leasing modern, high-demand and fuel-efficient commercial jet aircraft under long-term contracts to a diverse group of airlines throughout the world. The Company’s strategy is to effectively manage its fleet and grow its portfolio through accretive acquisitions of aircraft. FLY Leasing is managed and serviced by BBAM L.P., an aircraft leasing company. BBAM acts as manager of FLY Leasing and servicer of the aircraft portfolio under multi-year management and servicing agreements. In addition to arranging for the leasing of the fleet, BBAM assists in the acquiring and disposing of aircraft, marketeering aircraft for lease and release, collecting rents and other payments from the lessees of aircraft, monitoring maintenance, insurance and other obligations under leases, and enforcing FLY Leasing’s rights against lessees. BBAM is an independent company. FLY Leasing Limited is headquartered in Dublin, Ireland. “

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Flushing Financial (NASDAQ:FFIC) from a sell rating to a strong sell rating in a research report released on Wednesday.

  • [By Shane Hupp]

    Flushing Financial (NASDAQ:FFIC) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Friday.

  • [By Motley Fool Transcribers]

    Flushing Financial Corp  (NASDAQ:FFIC)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Warren Buffett Stocks To Watch For 2019: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Synopsys (NASDAQ:SNPS) Q3 2018 Earnings Conference CallAug. 22, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage gain ahead of the close was Synopsys, Inc. (NASDAQ: SNPS) which traded up over 6% at $100.70. The stock’s 52-week range is $77.91 to $101.76. Volume was about 4 million compared to the daily average volume of nearly 1 million.

  • [By Ethan Ryder]

    Royal London Asset Management Ltd. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 60,026 shares of the semiconductor company’s stock, valued at approximately $5,137,000.

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Warren Buffett Stocks To Watch For 2019: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By Daniel Miller]

    Shares of Advanced Auto Parts (NYSE:AAP), a leading automotive aftermarket parts provider for professional installers and do-it-yourself consumers, are up 8% as of 3:25 p.m. EDT Tuesday after a strong second-quarter result. In fact, the company’s strong earnings result even boosted the share price of its competitors: AutoZone, Inc. (NYSE:AZO) popped more than 5% during early afternoon trading, and O’Reilly Automotive (NASDAQ:ORLY) also logged a smaller 3% gain.

  • [By Chris Lange]

    Advance Auto Parts Inc. (NYSE: AAP) is scheduled to share its quarterly report early on Tuesday. The consensus estimates are $1.85 in EPS on revenue of $2.27 billion. Shares were last seen trading at $146.35. The stock has a 52-week range of $78.81 to $148.70, and the consensus price target is $135.13.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Advance Auto Parts, Inc. (NYSE: AAP) which rose 4% to $114.21. The stock’s 52-week range is $78.81 to $158.59. Volume was nearly 2 million compared to the daily average volume of 1.5 million.

Top 10 Warren Buffett Stocks To Watch For 2019: VALE S.A.(VALE)

Advisors’ Opinion:

  • [By Chris Hill]

    Next up, the Justice Department has formally charged Huawei with a list of crimes that include stealing trade secrets from T-Mobile (NASDAQ:TMUS) as well as bank and wire fraud. And while China will have the telecom and smartphone giant’s back, there’s probably no way this ends well. Finally, after last week’s Brumadinho dam disaster, which spilled 3 million gallons of contaminated mining waste, destroyed a town, and killed at least 65 people in Brazil, Vale (NYSE:VALE) shareholders have to be asking themselves if the company is doomed.

  • [By Stephan Byrd]

    Shares of Vale SA (NYSE:VALE) gapped down before the market opened on Monday . The stock had previously closed at $13.11, but opened at $12.82. Vale shares last traded at $12.49, with a volume of 13924600 shares.

  • [By Neha Chamaria]

    Wheaton first took the gold leap in 2013 when it struck an agreement with mining giant Vale (NYSE:VALE) to buy 25% of the gold produced from its Salobo mine in Brazil for the life of mine, as well as 70% of the gold produced from its Sudbury mines in Canada for a 20-year term. Wheaton paid $1.9 billion to Vale in addition to stock warrants for the deal.

  • [By Logan Wallace]

    Brookfield Asset Management Inc. purchased a new position in shares of Vale SA (NYSE:VALE) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 40,493 shares of the basic materials company’s stock, valued at approximately $515,000.

  • [By Reuben Gregg Brewer]

    In June Wheaton announced that it had purchased a cobalt stream from giant miner Vale S.A. (NYSE:VALE) for an up-front payment of $390 million. Starting in 2021 Wheaton will receive 42.4% of the Voisey’s Bay mine’s cobalt production until certain production targets are met, at which point it will receive half that amount. Wheaton’s cost will be pegged at 18% of the spot price for cobalt until certain financial targets are met, and will become 22% thereafter. Cobalt is a byproduct at this mine, which primarily produces nickel. Vale is using the cash to expand the mine, with a production ramp-up expected in 2021. 

Top 10 Warren Buffett Stocks To Watch For 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Keith Speights]

    When it comes to treating cystic fibrosis (CF), you have Vertex Pharmaceuticals (NASDAQ:VRTX) and, well, that’s pretty much it. However, Galapagos (NASDAQ:GLPG) still hopes to challenge Vertex in the CF market in the not-too-distant future. The clinical-stage biotech also could soon have a big winner outside of the CF indication.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    Around 44,000 CF patients have gene mutations that are addressable by Vertex’s current drugs. The company is moving forward with several late-stage studies of new triple-drug combinations that hold the potential to treat another 24,000 CF patients. While AbbVie (NYSE:ABBV) and Galapagos (NASDAQ:GLPG) are also developing triple-drug CF combos, Vertex has a clear head start.

Top 10 Warren Buffett Stocks To Watch For 2019: First Choice Healthcare Solutions, Inc. (FCHS)

Advisors’ Opinion:

  • [By Shane Hupp]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

  • [By Shane Hupp]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it compare to its rivals? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its earnings, dividends, analyst recommendations, institutional ownership, profitability, valuation and risk.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, profitability, earnings, analyst recommendations, dividends and institutional ownership.

  • [By Max Byerly]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare First Choice Healthcare Solutions to similar businesses based on the strength of its analyst recommendations, earnings, institutional ownership, profitability, risk, valuation and dividends.

  • [By Logan Wallace]

    First Choice Healthcare Solutions (OTCMKTS: FCHS) is one of 21 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare First Choice Healthcare Solutions to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

Top 10 Warren Buffett Stocks To Watch For 2019: GSE Systems, Inc.(GVP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Warren Buffett Stocks To Watch For 2019: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

  • [By Stephan Byrd]

    Lincoln National Corp acquired a new position in Western Asset Mortgage Capital Corp (NYSE:WMC) during the 2nd quarter, Holdings Channel reports. The fund acquired 11,000 shares of the financial services provider’s stock, valued at approximately $115,000.

Leave a Reply

Your email address will not be published. Required fields are marked *